Matinas Biopharma
MTNB----
Forecast & RatingOnly 1 analyst currently covers Matinas Biopharma (MTNB.US), with a price target of $450.00 and a rating of "Hold". The sample is very small, so treat this as a reference only. Data as of Sep 28, 2026; this does not constitute investment advice.
Apr 30, 2025Price forecast
$450.0037715.12%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateNov 2, 2026
Forecast met0.0%
Stock price$1.19
Avg. target$450.0
High target$450
Low target$450
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.